Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 3/20 | 0.37 |
| ▸ | PARP1 | P09874 | 2/20 | 0.34 |
| ▸ | CDK4 | P11802 | 5/20 | 0.33 |
| ▸ | CCND1 | P24385 | 5/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.33 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.33 |
| ▸ | GSK3A | P49840 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | CAMK2B | Q13554 | 3/20 | 0.33 |
| ▸ | CAMK2G | Q13555 | 3/20 | 0.33 |
| ▸ | CAMK2D | Q13557 | 3/20 | 0.33 |
| ▸ | CAMK2A | Q9UQM7 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.33 |
| ▸ | PRKCG | P05129 | 2/20 | 0.33 |
| ▸ | PRKCB | P05771 | 2/20 | 0.33 |
| ▸ | PRKCA | P17252 | 2/20 | 0.33 |
| ▸ | PRKCH | P24723 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13776690 | 0.79 | PDK2 (0.30) | HTR2B | |
| SCHEMBL13776681 | 0.79 | PDK2 (0.31) | HTR2B | |
| SCHEMBL13776707 | 0.79 | PDK2 (0.31) | HTR2B | |
| SCHEMBL13776682 | 0.79 | MLNR (0.31) | HTR2B | |
| SCHEMBL13776684 | 0.79 | PDK2 (0.31) | — | |
| SCHEMBL22402000 | 0.77 | PARP14 (0.33) | CDK4CCND1CCNE2CCNE1CDK2 | |
| SCHEMBL24730495 | 0.77 | CHEK1 (0.44) | CHEK1PARP1CDK4CCND1CDK5 | |
| SCHEMBL25954138 | 0.77 | ALOX5 (0.32) | — | |
| SCHEMBL18012352 | 0.76 | CRHR1 (0.30) | — | |
| SCHEMBL15840240 | 0.76 | PGR (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230134334-A1 | AMINE COMPOUND HAVING FUSED RING, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20230134334-A1 | AMINE COMPOUND HAVING FUSED RING, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD (KR) | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230134334-A1 | AMINE COMPOUND HAVING FUSED RING, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | EML4, SLC18A2, TYR | CHEK1 3544/4885PARP1 2631/4885CDK4 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.